NEXTSEQ 2000 P3 Trademark

Trademark Overview

On Monday, January 13, 2020, a trademark application was filed for NEXTSEQ 2000 P3 with the United States Patent and Trademark Office. The USPTO has given the NEXTSEQ 2000 P3 trademark a serial number of 88756705. The federal status of this trademark filing is REGISTERED as of Tuesday, January 16, 2024. This trademark is owned by Illumina, Inc.. The NEXTSEQ 2000 P3 trademark is filed in the Pharmaceutical Products category with the following description:

Biological diagnostic agents, reagents, medical diagnostic assays, enzymes, nucleotides for medical purposes, buffers for disease testing, for medical and veterinary use; diagnostic reagents and preparations for medical and veterinary use; Kits containing reagents and a protocol for use thereof for medical purposes; kits comprised of nucleotides for medical purposes, reagents, enzyme substrates, buffers for disease testing, for medical genetic testing and medical diagnostic purposes; biological diagnostic agents, reagents, medical diagnostic assays, enzymes, nucleotides for medical purposes, buffers for disease testing, for medical and veterinary use in the fields of medical diagnostics, clinical diagnostics, veterinary diagnostics, medical forensics, laboratory medicine, veterinary medicine, genetic testing, and genetics
nextseq 2000 p3

General Information

Serial Number88756705
Word MarkNEXTSEQ 2000 P3
Filing DateMonday, January 13, 2020
Status700 - REGISTERED
Status DateTuesday, January 16, 2024
Registration Number7279589
Registration DateTuesday, January 16, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 13, 2021

Trademark Statements

Goods and ServicesBiological diagnostic agents, reagents, medical diagnostic assays, enzymes, nucleotides for medical purposes, buffers for disease testing, for medical and veterinary use; diagnostic reagents and preparations for medical and veterinary use; Kits containing reagents and a protocol for use thereof for medical purposes; kits comprised of nucleotides for medical purposes, reagents, enzyme substrates, buffers for disease testing, for medical genetic testing and medical diagnostic purposes; biological diagnostic agents, reagents, medical diagnostic assays, enzymes, nucleotides for medical purposes, buffers for disease testing, for medical and veterinary use in the fields of medical diagnostics, clinical diagnostics, veterinary diagnostics, medical forensics, laboratory medicine, veterinary medicine, genetic testing, and genetics
Pseudo MarkNEXT SEQ TWO THOUSAND P THREE; NEXT SEQ TWO ZERO ZERO ZERO P THREE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 16, 2020
Primary Code005
First Use Anywhere DateMonday, January 13, 2020
First Use In Commerce DateFriday, October 9, 2020

Trademark Owner History

Party NameIllumina, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122
Party NameIllumina, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122
Party NameIllumina, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122

Trademark Events

Event DateEvent Description
Monday, January 22, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 16, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 16, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 16, 2024REGISTERED-PRINCIPAL REGISTER
Friday, December 15, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, December 14, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, December 6, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, December 4, 2023USE AMENDMENT FILED
Monday, December 4, 2023TEAS STATEMENT OF USE RECEIVED
Friday, May 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 17, 2023SOU EXTENSION 4 GRANTED
Wednesday, May 17, 2023SOU EXTENSION 4 FILED
Wednesday, May 17, 2023SOU TEAS EXTENSION RECEIVED
Friday, December 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 30, 2022SOU EXTENSION 3 GRANTED
Wednesday, November 30, 2022SOU EXTENSION 3 FILED
Wednesday, November 30, 2022SOU TEAS EXTENSION RECEIVED
Thursday, June 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 23, 2022CORRECTED NOA E-MAILED
Wednesday, June 22, 2022DIVISIONAL PROCESSING COMPLETE
Friday, June 3, 2022DIVISIONAL REQUEST RECEIVED
Wednesday, June 22, 2022SOU EXTENSION 2 GRANTED
Friday, June 3, 2022SOU EXTENSION 2 FILED
Tuesday, June 21, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 3, 2022TEAS REQUEST TO DIVIDE RECEIVED
Friday, June 3, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 6, 2021SOU EXTENSION 1 GRANTED
Monday, December 6, 2021SOU EXTENSION 1 FILED
Monday, December 6, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, June 8, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 13, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 5, 2021EXPARTE APPEAL TERMINATED
Friday, March 5, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 4, 2021ASSIGNED TO LIE
Friday, February 26, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, February 26, 2021EX PARTE APPEAL-INSTITUTED
Friday, February 26, 2021JURISDICTION RESTORED TO EXAMINING ATTORNEY
Friday, February 26, 2021EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, August 26, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, August 26, 2020FINAL REFUSAL E-MAILED
Wednesday, August 26, 2020FINAL REFUSAL WRITTEN
Thursday, August 6, 2020PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, August 6, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, August 5, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 4, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 4, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 29, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 29, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 23, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 25, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, February 5, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 5, 2020NON-FINAL ACTION E-MAILED
Wednesday, February 5, 2020NON-FINAL ACTION WRITTEN
Thursday, January 30, 2020ASSIGNED TO EXAMINER
Thursday, January 16, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 16, 2020NEW APPLICATION ENTERED

Related Keywords

nextseq medical diagnostic testing reagents veterinary purposes buffers diagnostics disease nucleotides